Bioceres Crop Solutions (BIOX) Common Equity (2016 - 2026)

Bioceres Crop Solutions has disclosed Common Equity across 11 years of filings, most recently posting $91.7 million for Q1 2026.

• In Q1 2026, Common Equity fell 73.42% year-over-year to $91.7 million; the TTM figure through Mar 2026 stood at $91.7 million (down 73.42% YoY), while the FY2025 annual figure was $295.2 million, down 15.99% from the prior year.
• Common Equity came in at $91.7 million for Q1 2026 at Bioceres Crop Solutions, down from $106.6 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $351.4 million in Q2 2024 to a low of $91.7 million in Q1 2026.
• Average Common Equity over 5 years is $279.3 million, with a median of $330.5 million recorded in 2023.
• Year-over-year, Common Equity jumped 221.75% in 2022 and slumped 73.42% in 2026.
• Over 5 years, Common Equity stood at $306.6 million in 2022, then advanced by 9.34% to $335.3 million in 2023, then increased by 3.3% to $346.3 million in 2024, then tumbled by 69.22% to $106.6 million in 2025, then dropped by 13.99% to $91.7 million in 2026.
• Per Business Quant data, the three most recent Common Equity figures were $91.7 million in Q1 2026, $106.6 million in Q4 2025, and $288.3 million in Q3 2025.